As a core support for perioperative medical care, the mechanisms of action of anesthetic products are based on the interdisciplinary foundation of neuroscience, pharmacology, and physiology.They aim to intervene in the transmission of nerve signals and physiological reflexes through specific substances or technologies, thereby achieving multiple goals such as loss of consciousness, pain blockade, muscle relaxation, and stress inhibition. A deep understanding of their mechanisms of action not only helps optimize clinical protocols but also provides a theoretical basis for the development and safe application of novel anesthetic products.
The principles of general anesthesia products mainly revolve around the reversible inhibition of the central nervous system. Intravenous anesthetics (such as propofol and barbiturates) enhance GABA-mediated inhibitory neurotransmission or inhibit the activity of excitatory amino acid (such as glutamate) receptors, reducing the excitability of the cerebral cortex and thalamus, thus inducing sedation, hypnosis, or even loss of consciousness in patients. Inhaled anesthetics (such as sevoflurane and isoflurane) diffuse into nerve cell membranes due to their lipid solubility and high affinity for brain tissue, altering ion channel conformation and neurotransmitter release patterns, thereby inhibiting central integrative function. The synergistic effect of inhaled anesthetics and isoflurane maintains appropriate depth of anesthesia throughout surgery, while controlling induction and awakening by regulating alveolar concentration and intracranial partial pressure.
Local anesthetics work on the principle of peripheral nerve conduction blockade. Commonly used drugs (such as lidocaine and ropivacaine) bind to voltage-gated sodium channels on nerve fiber membranes, preventing sodium ion influx and inhibiting action potential generation and conduction, thus blocking the transmission of pain, temperature, and tactile signals at the injection site. Their range of action depends on drug concentration, dosage, and injection site; high concentrations can cause motor nerve blockade, while low concentrations preserve motor function, meeting different clinical needs. Furthermore, the differences in lipid solubility of local anesthetics affect their diffusion rate and duration, providing a basis for personalized selection of surgical procedures and analgesia regimens.
The mechanism of action of muscle relaxants is independent of consciousness and pain modulation. They primarily achieve skeletal muscle relaxation by interfering with signal transmission at the neuromuscular junction. Depolarizing muscle relaxants (such as succinylcholine) mimic the action of acetylcholine, continuously activating nicotinic acetylcholine receptors, causing persistent membrane depolarization and resulting in muscle paralysis. Non-depolarizing muscle relaxants (such as vecuronium and rocuronium) competitively occupy receptors, preventing acetylcholine binding and thus interrupting nerve impulse-induced contractions. These drugs are only used in conjunction with mechanical ventilation and must be used in combination with adequate doses of sedatives and analgesics to prevent intraoperative awareness and discomfort.
The principle of adjunctive anesthetic medications is to optimize the overall anesthetic effect and reduce adverse reactions. Opioid analgesics (such as fentanyl and sufentanil) activate μ receptors, inhibiting pain transmission pathways in the spinal cord and brain, raising the pain threshold, and lowering stress hormone levels. Alpha₂ receptor agonists (such as dexmedetomidine) act on the locus coeruleus, producing sedative, anxiolytic, and sympathetic inhibitory effects, offering the advantages of stabilizing circulation and reducing anesthetic dosage. Anticholinergic drugs block M receptors, inhibiting glandular secretion and vagal reflexes, ensuring airway humidification and heart rate stability.
Modern anesthesia products also incorporate monitoring and feedback mechanisms. Electroencephalography (EEG) monitoring (such as BIS and entropy index) quantifies the depth of anesthesia by analyzing cortical electrical activity characteristics, providing a basis for drug dosage adjustments. Muscle relaxation monitoring assesses the level of blockade based on the attenuation of peripheral nerve stimulation-induced responses, guiding the timing of muscle relaxant discontinuation. The application of these principles shifts anesthesia from experience-driven to precise control, significantly reducing risks such as intraoperative awareness, circulatory fluctuations, and postoperative cognitive impairment.
Overall, the mechanism of action of anesthetic products is based on reversible neurofunctional intervention, creating safe, painless, and muscle-relaxed ideal conditions for surgical procedures and critical care management through the synergistic effects of multiple targets and mechanisms. With the development of molecular pharmacology and neuromodulation technology, research into its principles will continue to deepen, driving anesthetic products towards greater precision and personalization.